Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito

Articles

Online First

Fibromyalgia as a Disorder of Multi-System Regulation: From Pathogenetic Modeling to Therapeutic Perspectives

DOI
https://doi.org/10.3280/pnei2026oa24255
Inviata
novembre 10, 2026
Pubblicato
18-11-2026

Abstract

Fibromyalgia (FM) is a multifactorial syndrome characterized by chronic widespread
pain and associated symptoms. Despite evidence implicating central nervous system dysfunction
and psychoneuroendocrine interactions, its pathogenesis remains unclear, limiting the
development of mechanism-based therapies. We discuss FM within the frameworks of Psychoneuroendocrinoimmunology
and Dynamical Systems Theory, proposing a pathogenetic model
based on interactions between neuroendocrine and thalamocortical regulatory circuits. The model
hypothesizes that an imbalance between GABAergic inhibition and glutamatergic excitation,
potentially driven by stress and gonadal hormones, may promote a stable state of increased neuronal
activity. This framework may help explain the association of FM with stress and its higher
prevalence in women. Although not yet experimentally validated, the model is consistent with
several literature findings and suggests potential therapeutic targets, including neurosteroids,
non-invasive brain stimulation, mind-body therapies and dietary interventions. Overall, this
framework may help reconceptualize FM as a disorder of dynamically dysregulated, interconnected
systems and guide the development of individualized, mechanism-oriented therapeutic
strategies.

Riferimenti bibliografici

  1. Ahmed, I., Mustafaoglu, R., Memon, A. R., Zafeer, R., Xiong, H., Straudi, S., & Runge, N. (2025). Comparative Effectiveness of Noninvasive Brain Stimulation for the Treatment of Pain, Fatigue, and Sleep Quality in Fibromyalgia. A Systematic Review With Network Meta-Analysis. Clin J Pain, 41(5). Doi: 10.1097/AJP.0000000000001282
  2. Aloisi, A. M., & Sorda, G. (2011). Relationship of female sex hormones with pain perception: focus on estrogens. Pain Manag, 1(3), 229–238. Doi: 10.2217/pmt.11.13
  3. Alonso, C., Loevinger, B. L., Muller, D., & Coe, C. L. (2004). Menstrual cycle influences on pain and emotion in women with fibromyalgia. J Psychosom Res, 57(5), 451–458. Doi: 10.1016/j.jpsychores.2004.05.003
  4. Angeline, S., Tiyatiye, B., & Akosile, W. (2025). Transcranial Magnetic Stimulation in Pregnancy: Efficacy, Safety, and Future Implications for Perinatal Mental Health Care. Brain Behav, 15(2), e70304. Doi: 10.1002/brb3.70304
  5. Arout, C. A., Sofuoglu, M., Bastian, L. A., & Rosenheck, R. A. (2018). Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study. J Womens Health (Larchmt), 27(8), 1035–1044. Doi: 10.1089/jwh.2017.6622
  6. Beiner, E., Hermes, M., Reichert, J., Kleinke, K., Vock, S., Loffler, A., Ader, L., Sirazitdinov, A., Keil, S., Schmidt, T., Schick, A., Loffler, M., Hopp, M., Ruckes, C., Hesser, J., Reininghaus, U., Flor, H., Eich, W., & Tesarz, J. (2025). Early-life adversity as a predictor of fibromyalgia syndrome: the central role of perceived stress over endocrine stress indicators. Pain, 166(8), 1871–1881. Doi: 10.1097/j.pain.0000000000003527
  7. Beiner, E., Lucas, V., Reichert, J., Buhai, D. V., Jesinghaus, M., Vock, S., Drusko, A., Baumeister, D., Eich, W., Friederich, H. C., & Tesarz, J. (2023). Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis. Pain, 164(7), 1416–1427. Doi: 10.1097/j.pain.0000000000002857
  8. Blanchini, F., Franco, E., & Giordano, G. (2014). A structural classification of candidate oscillatory and multistationary biochemical systems. Bull Math Biol, 76(10), 2542–2569. Doi: 10.1007/s11538-014-0023-y
  9. Burlando, B. (2022). A general hypothesis of multistable systems in pathophysiology. F1000Res, 11, 906. Doi: 10.12688/f1000research.123183.3
  10. Burlando, B., & Demori, I. (2024). Neurosteroids as a possible new horizon in the treatment of fibromyalgia. Medical Hypotheses, 191. Doi: 10.1016/j.mehy.2024.111444
  11. Chaieb, L., Antal, A., & Paulus, W. (2008). Gender-specific modulation of short-term neuroplasticity in the visual cortex induced by transcranial direct current stimulation. Vis Neurosci, 25(1), 77–81. Doi: 10.1017/S0952523808080097
  12. Ciaffi, J., Lisi, L., Mari, A., Mancarella, L., Brusi, V., Pignatti, F., Ricci, S., Vitali, G., Stefanelli, N., Assirelli, E., Neri, S., Naldi, S., Faldini, C., & Ursini, F. (2023). Efficacy, safety and tolerability of very low-calorie ketogenic diet in obese women with fibromyalgia: a pilot interventional study. Front Nutr, 10, 1219321. Doi: 10.3389/fnut.2023.1219321
  13. Clos-Garcia, M., Andres-Marin, N., Fernandez-Eulate, G., Abecia, L., Lavin, J. L., van Liempd, S.,
  14. Cabrera, D., Royo, F., Valero, A., Errazquin, N., Vega, M. C. G., Govillard, L., Tackett, M. R., Tejada, G., Gonzalez, E., Anguita, J., Bujanda, L., Orcasitas, A. M. C., Aransay, A. M.,…Falcon-Perez, J. M. (2019). Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine, 46, 499–511. Doi: 10.1016/j.ebiom.2019.07.031
  15. D'Souza, R. S., Klasova, J., Morsi, M., Vincent, A., Mohabbat, A. B., Whitfield, S., Radlicz, C., Sheen, S., Wang, D., Zhitnitsky, M., Saini, C., Al-Hindawi, A., Lopez, K., To, J., Chitneni, A., Graca, M., Gill, B., Her, Y. F., Prokop, L. J., & Hussain, N. (2026). The Prevalence of Fibromyalgia in the General Population and At-Risk Subpopulations: A Systematic Review and Meta-Analysis. Anesth Analg. Doi: 10.1213/ANE.0000000000008098
  16. Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol, 16(8), 461–478. Doi: 10.1038/s41575-019-0157-3
  17. Demori, I., Giordano, G., Mucci, V., Losacco, S., Marinelli, L., Massobrio, P., Blanchini, F., & Burlando, B. (2022). Thalamocortical bistable switch as a theoretical model of fibromyalgia pathogenesis inferred from a literature survey. J Comput Neurosci, 50(4), 471–484. Doi: 10.1007/s10827-022-00826-8
  18. Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B. (2024). Fibromyalgia pathogenesis explained by a neuroendocrine multistable model. PLoS One, 19(7), e0303573. Doi: 10.1371/journal.pone.0303573
  19. Demori, I., Molinari, E., Rapallo, F., Mucci, V., Marinelli, L., Losacco, S., & Burlando, B. (2022). Online Questionnaire with Fibromyalgia Patients Reveals Correlations among Type of Pain, Psychological Alterations, and Effectiveness of Non-Pharmacological Therapies. Healthcare (Basel), 10(10). Doi: 10.3390/healthcare10101975
  20. El-Samad, H. (2021). Biological feedback control-Respect the loops. Cell Syst, 12(6), 477–487. Doi: 10.1016/j.cels.2021.05.004
  21. Fernandez-Rodriguez, F. J., Delgado-Perez, E., Salgado-Ortiz, C. S., Quishpe-Rivera, E. A., & Sosa-Reina, M. D. (2026). Inflammatory biomarker alterations in patients with fibromyalgia: a systematic review and meta-analysis. BMC Rheumatol, 10(1). Doi: 10.1186/s41927-026-00677-1
  22. Fitzgerald, C. T., & Carter, L. P. (2011). Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: a conceptual model for chronic pain. Med Hypotheses, 77(3), 409–415. Doi: 10.1016/j.mehy.2011.05.031
  23. Foerster, B. R., Petrou, M., Edden, R. A., Sundgren, P. C., Schmidt-Wilcke, T., Lowe, S. E., Harte, S. E., Clauw, D. J., & Harris, R. E. (2012). Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum, 64(2), 579–583. Doi: 10.1002/art.33339
  24. Freyer, F., Roberts, J. A., Ritter, P., & Breakspear, M. (2012). A canonical model of multistability and scale-invariance in biological systems. PLoS Comput Biol, 8(8), e1002634. Doi: 10.1371/journal.pcbi.1002634
  25. Genc, H., Atasever, M., Duyur Cakit, B., Seval, M., & Koc, A. (2017). The Effects of Fibromyalgia Syndrome on Physical Function and Psychological Status of Pregnant Females. Arch Rheumatol, 32(2), 129–140. Doi: 10.5606/ArchRheumatol.2017.6028
  26. Groh, A., Krieger, P., Mease, R. A., & Henderson, L. (2018). Acute and Chronic Pain Processing in the Thalamocortical System of Humans and Animal Models. Neuroscience, 387, 58–71. Doi: 10.1016/j.neuroscience.2017.09.042
  27. Iannuccelli, C., Favretti, M., Bianchi, B., Dolcini, G., Cauli, C., Ferraro, V., Gioia, C., Bazzichi, L., Atzeni, F., Batticciotto, A., Galli, F., Varrassi, G., Ablin, J. N., Gualtierotti, R., Conti, F., Di Franco, M., Salaffi, F., Sarzi-Puttini, P., Di Carlo, M., & Pain Study Group of the Italian Society of, R. (2026). Pathogenetic and clinical aspects of fibromyalgia: one year in review 2026. Clin Exp Rheumatol, 44(6), 1057–1068. Doi: 10.55563/clinexprheumatol/asx3uo
  28. Iannuccelli, C., Favretti, M., Dolcini, G., Di Carlo, M., Pellegrino, G., Bazzichi, L., Atzeni, F., Lucini, D., Varassi, G., Leoni, M. L. G., Fornasari, D. M. M., Conti, F., Salaffi, F., Sarzi-Puttini, P., & Di Franco, M. (2025). Fibromyalgia: one year in review 2025. Clin Exp Rheumatol, 43(6), 957–969. Doi: 10.55563/clinexprheumatol/buhd2z
  29. Jaeger, J., & Monk, N. (2014). Bioattractors: dynamical systems theory and the evolution of regulatory processes. J Physiol, 592(11), 2267–2281. Doi: 10.1113/jphysiol.2014.272385
  30. Jurado-Priego, L. N., Cueto-Urena, C., Ramirez-Exposito, M. J., & Martinez-Martos, J. M. (2024). Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies. Biomedicines, 12(7). Doi: 10.3390/biomedicines12071543
  31. Kerrebijn, I., Bjornsdottir, G., Arbabi, K., Urpa, L., Haapaniemi, H., Thorleifsson, G., Stefansdottir, L., Frangakis, S., Valliere, J., Kunorozva, L., Abner, E., Ji, C., Kangur, M., Aagaard, B., Bliddal, H., Brunak, S., Bruun, M. T., Didriksen, M., Erikstrup, C.,…Wainberg, M. (2026). The genetic architecture of fibromyalgia across 2.5 million individuals. Nat Med, 32(8), 3060–3070. Doi: 10.1038/s41591-026-04492-6
  32. Kosek, E. (2024). The concept of nociplastic pain-where to from here? Pain, 165(11S), S50–S57. Doi: 10.1097/j.pain.0000000000003305
  33. Kulekcioglu, S. (2022). Diagnostic difficulty, delayed diagnosis, and increased tendencies of surgical treatment in fibromyalgia syndrome. Clin Rheumatol, 41(3), 831–837. Doi: 10.1007/s10067-021-05970-7
  34. Lam, Y. W., & Sherman, S. M. (2011). Functional organization of the thalamic input to the thalamic reticular nucleus. J Neurosci, 31(18), 6791–6799. Doi: 10.1523/JNEUROSCI.3073-10.2011
  35. Laurin, A., Nard, N., Dalmont, M., Bulteau, S., Benard, C., Bonnot, O., Winer, N., Dupont, F., Apter, G., Terranova-Commessie, F., Guillin, O., El-Hage, W., Sauvaget, A., & Rotharmel, M. (2022). Efficacy and Safety of Transcranial Electric Stimulation during the Perinatal Period: A Systematic Literature Review and Three Case Reports. J Clin Med, 11(14). Doi: 10.3390/jcm11144048
  36. Liu, Y. Z., Wang, Y. X., & Jiang, C. L. (2017). Inflammation: The Common Pathway of Stress-Related Diseases. Front Hum Neurosci, 11, 316. Doi: 10.3389/fnhum.2017.00316
  37. Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Hauser, W., Fluss, E., Choy, E., Kosek, E., Amris, K., Branco, J., Dincer, F., Leino-Arjas, P., Longley, K., McCarthy, G. M., Makri, S., Perrot, S., Sarzi-Puttini, P., Taylor, A., & Jones, G. T. (2017). EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis, 76(2), 318–328. Doi: 10.1136/annrheumdis-2016-209724
  38. Maguire, J. L., & Mennerick, S. (2024). Neurosteroids: mechanistic considerations and clinical prospects. Neuropsychopharmacology, 49(1), 73–82. Doi: 10.1038/s41386-023-01626-z
  39. Miller, E. E., Jayakrishnan, S., Froio, F., Ahmed, D., Haq, H., Schnurer, S., Messina, M. V., Barillà, B., Saturnino, A., Vomero, M., Marino, A., Navarini, L., Giacomelli, R., Karamagioli, E., Pozzilli, P., & Zoughbie, D. E. (2025). Mediterranean diet and its low-antigenic and anti-inflammatory properties on fibromyalgia: a systematic review. Clinical and Experimental Rheumatology. Doi: 10.55563/clinexprheumatol/2usk4p
  40. Minerbi, A., Gonzalez, E., Brereton, N. J. B., Anjarkouchian, A., Dewar, K., Fitzcharles, M. A., Chevalier, S., & Shir, Y. (2019). Altered microbiome composition in individuals with fibromyalgia. Pain, 160(11), 2589–2602. Doi: 10.1097/j.pain.0000000000001640
  41. Mucci, V., Demori, I., Browne, C. J., Deblieck, C., & Burlando, B. (2023). Fibromyalgia in Pregnancy: Neuro-Endocrine Fluctuations Provide Insight into Pathophysiology and Neuromodulation Treatment. Biomedicines, 11(2). Doi: 10.3390/biomedicines11020615
  42. Ostensen, M., Rugelsjoen, A., & Wigers, S. H. (1997). The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol, 26(5), 355–360. Doi: 10.3109/03009749709065698
  43. Pinto, A. M., Luis, M., Geenen, R., Palavra, F., Lumley, M. A., Ablin, J. N., Amris, K., Branco, J., Buskila, D., Castelhano, J., Castelo-Branco, M., Crofford, L. J., Fitzcharles, M. A., Hauser, W., Kosek, E., Mease, P. J., Marques, T. R., Jacobs, J. W. G., Castilho, P., & da Silva, J. A. P. (2023). Neurophysiological and psychosocial mechanisms of fibromyalgia: A comprehensive review and call for an integrative model. Neurosci Biobehav Rev, 151, 105235. Doi: 10.1016/j.neubiorev.2023.105235
  44. Proietti, E., Rapallo, F., Molinari, E., Mucci, V., Marinelli, L., Borgarelli, C., Burlando, B., Pisciotta, L., & Demori, I. (2024). Online Questionnaire with Fibromyalgia Patients Shows Negative Correlations between Disease Severity and Adherence to Mediterranean Diet. Nutrients, 16(7). Doi: 10.3390/nu16071078
  45. Qiao, Y. N., Li, L., Hu, S. H., Yang, Y. X., Ma, Z. Z., Huang, L., An, Y. P., Yuan, Y. Y., Lin, Y., Xu, W., Li,
  46. Y., Lin, P. C., Cao, J., Zhao, J. Y., & Zhao, S. M. (2024). Ketogenic diet-produced beta-hydroxybutyric acid accumulates brain GABA and increases GABA/glutamate ratio to inhibit epilepsy. Cell Discov, 10(1), 17. Doi: 10.1038/s41421-023-00636-x
  47. Salaffi, F., Di Carlo, M., Bazzichi, L., Atzeni, F., Govoni, M., Biasi, G., Di Franco, M., Mozzani, F., Gremese, E., Dagna, L., Batticciotto, A., Fischetti, F., Giacomelli, R., Guiducci, S., Guggino, G., Bentivegna, M., Gerli, R., Salvarani, C., Bajocchi, G.,…Sarzi-Puttini, P. (2021). Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients. Rheumatology (Oxford), 60(2), 728–736. Doi: 10.1093/rheumatology/keaa355
  48. Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020). Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol, 16(11), 645–660. Doi: 10.1038/s41584-020-00506-w
  49. Tzadok, R., & Ablin, J. N. (2020). Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Res Manag, 2020, 6541798. Doi: 10.1155/2020/6541798
  50. Ustianowska, K., Ustianowski, L., Machaj, F., Goracy, A., Rosik, J., Szostak, B., Szostak, J., & Pawlik,
  51. A. (2022). The Role of the Human Microbiome in the Pathogenesis of Pain. Int J Mol Sci, 23(21). Doi: 10.3390/ijms232113267
  52. Vidal-Neira, L. F., Neyro, J. L., Maldonado, G., Messina, O. D., Moreno-Alvarez, M., & Rios, C. (2024). Climacteric and fibromyalgia: a review. Climacteric, 27(5), 458–465. Doi: 10.1080/13697137.2024.2376190
  53. Wise, P. M. (2002). Estrogens and neuroprotection. Trends Endocrinol Metab, 13(6), 229–230. Doi: 10.1016/s1043-2760(02)00611-2
  54. Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Hauser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016). 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum, 46(3), 319–329. Doi: 10.1016/j.semarthrit.2016.08.012
  55. Wu, E., Brener, A., Hiser, J. K. D., Hill, D. L. K., & Farmer, J. O. (2025). Fibromyalgia: Update on pathogenesis and management. European Journal of Rheumatology, 12(4), e25032. Doi: 10.5152/eurjrheum.2025.25032